Scholars Central

Conference abstractPublished 26 Jun 2017

Bioequivalence inspection

Authors: Ashish A Mungantiwar

Macleods Pharmaceuticals Ltd., India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Bioequivalence study is conducted on healthy volunteer/patient to compare pharmacokinetic parameter of test product and reference product. Generic company conducting/sponsoring the study should be aware of risks of rejection and non-compliance. Methodology & Theoretical Orientation: Current topic will cover list of inspection findings from various regulatory agencies like US, EU and WHO and how to be ready for unannounced inspection, presentation will discuss current inspection trends and queries asked during dossier assessment. Conclusion & Significance: This presentation will critically review inspector and assessors expectation on bioequivalence Understanding such expectation will help for early and successful approval of the product.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Bioanalysis & Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ashish A Mungantiwar”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels